Evedientes, Jun Mae .

HRN: 23-53-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
AMPICILLIN 250MG (VIAL)
09/01/2023
09/07/2023
IVT
225mg
Q12
Pcap C
Waiting Final Action 
09/01/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/01/2023
09/07/2023
IVT
22.5
Od
Pcap C
09/07/2023
CEFTAZIDIME 1GM (VIAL)
09/07/2023
09/13/2023
IVTT
210 Mg
Q8
PCAP C
Waiting Final Action 
09/08/2023
MUPIROCIN 2%, 15G (TUBE)
09/08/2023
09/14/2023
TOPICAL
2%
BID
Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: